Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilm.

The activity of moxifloxacin was compared with ofloxacin and doxycycline against bacteria associated with periodontitis within a biofilm (single strain and mixed population) in vitro. MICs and minimal bactericidal concentrations (MBCs) of moxifloxacin, ofloxacin and doxycyline were determined against single strains and mixed populations in a planktonic state. Single-species biofilms of two Porphyromonas gingivalis and two Aggregatibacter actinomycetemcomitans strains and a multispecies biofilm consisting of 12 species were formed for 3 days. The minimal biofilm eradication concentrations (MBECs) were determined after exposing the biofilms to the antibacterials (0.002-512 µg ml(-1)) for 18 h, addition of nutrient broth for 3 days and subsequent subcultivation. Photographs were taken using confocal laser-scanning microscopy and scanning electron microscopy. The MICs and MBCs did not differ between ofloxacin and moxifloxacin against A. actinomycetemcomitans, whilst moxifloxacin was more active than the other tested antibacterials against anaerobes and the mixed population. The single-species biofilms were eradicated by moderate concentrations of the antibacterials, and the lowest MBECs were always found for moxifloxacin (2-8 µg ml(-1)). MBECs against the multispecies biofilms were 128, >512 and >512 µg ml(-1) for moxifloxacin, ofloxacin and doxycycline, respectively. In summary, moxifloxacin in a topical formulation may have potential as an adjunct to mechanical removal of the biofilms.

[1]  T. Thurnheer,et al.  Validation of antibiotic efficacy on in vitro subgingival biofilms. , 2014, Journal of periodontology.

[2]  T. Sorsa,et al.  Azithromycin as an adjunctive treatment of generalized severe chronic periodontitis: clinical, microbiologic, and biochemical parameters. , 2012, Journal of periodontology.

[3]  A. Monaco,et al.  Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis. , 2012, Journal of periodontology.

[4]  A. Monaco,et al.  Effectiveness of systemic amoxicillin/metronidazole as an adjunctive therapy to full-mouth scaling and root planing in the treatment of aggressive periodontitis: a systematic review and meta-analysis. , 2012, Journal of periodontology.

[5]  N. Lang,et al.  Effects of a single topical doxycycline administration adjunctive to mechanical debridement in patients with persistent/recurrent periodontitis but acceptable oral hygiene during supportive periodontal therapy. , 2012, Journal of clinical periodontology.

[6]  A. Monaco,et al.  Long-term efficacy of subantimicrobial-dose doxycycline as an adjunctive treatment to scaling and root planing: a systematic review and meta-analysis. , 2011, Journal of periodontology.

[7]  D. D’Argenio,et al.  Pharmacokinetics of Doxycycline in Adults with Cystic Fibrosis , 2011, Antimicrobial Agents and Chemotherapy.

[8]  J. Karbach,et al.  Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model. , 2011, Journal of periodontology.

[9]  C. Tomasi,et al.  Locally delivered doxycycline as an adjunct to mechanical debridement at retreatment of periodontal pockets: outcome at furcation sites. , 2011, Journal of periodontology.

[10]  T. Attin,et al.  Biofilm reduction and staining potential of a 0.05% chlorhexidine rinse containing essential oils. , 2011, International journal of dental hygiene.

[11]  C. Badet,et al.  The in vitro effect of manuka honeys on growth and adherence of oral bacteria. , 2011, Anaerobe.

[12]  K. Wegscheider,et al.  Comparative Efficacy and Safety of Moxifloxacin and Clindamycin in the Treatment of Odontogenic Abscesses and Inflammatory Infiltrates: a Phase II, Double-Blind, Randomized Trial , 2010, Antimicrobial Agents and Chemotherapy.

[13]  J. Potempa,et al.  Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. , 2010, Periodontology 2000.

[14]  H. Nagaraja,et al.  Subgingival Microbial Profiles of Smokers with Periodontitis , 2010, Journal of dental research.

[15]  C. Ardila,et al.  Antibiotic resistance of subgingival species in chronic periodontitis patients. , 2010, Journal of periodontal research.

[16]  Robert J. Palmer,et al.  Oral multispecies biofilm development and the key role of cell–cell distance , 2010, Nature Reviews Microbiology.

[17]  A. Heinecke,et al.  Eradication of Actinobacillus actinomycetemcomitans from the oral cavity in adult periodontitis. , 2010, Journal of periodontal research.

[18]  Thomas Bjarnsholt,et al.  Antibiotic resistance of bacterial biofilms. , 2010, International journal of antimicrobial agents.

[19]  K. Gomi,et al.  One-stage full-mouth versus partial-mouth scaling and root planing during the effective half-life of systemically administered azithromycin. , 2009, Journal of periodontology.

[20]  T. Hoffmann,et al.  Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis. , 2008, Journal of periodontology.

[21]  M. Zilberman,et al.  Antibiotic-eluting medical devices for various applications. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[22]  M. Sanz,et al.  Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. , 2008, Journal of clinical periodontology.

[23]  R. Oppermann,et al.  Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial. , 2008, Journal of clinical periodontology.

[24]  A. Schito,et al.  Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. , 2007, International journal of antimicrobial agents.

[25]  K. Okuda,et al.  Susceptibility of Actinobacillus actinomycetemcomitans to six antibiotics decreases as biofilm matures. , 2006, The Journal of antimicrobial chemotherapy.

[26]  Lingmin He,et al.  Prospective randomized study determining whether a 3-day application of ofloxacin results in the selection of fluoroquinolone-resistant coagulase-negative Staphylococcus. , 2006, European journal of ophthalmology.

[27]  A. V. van Winkelhoff,et al.  Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. , 2005, Journal of clinical periodontology.

[28]  S. Socransky,et al.  Periodontal microbial ecology. , 2005, Periodontology 2000.

[29]  S. Eick,et al.  Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study. , 2004, Journal of periodontology.

[30]  S. Eick,et al.  In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains. , 2004, The Journal of antimicrobial chemotherapy.

[31]  S. Block,et al.  Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial. , 2004, Clinical therapeutics.

[32]  S. Eick,et al.  Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study. , 2004, Journal of clinical periodontology.

[33]  G. Di Bonaventura,et al.  Biofilm Formation by Stenotrophomonas maltophilia: Modulation by Quinolones, Trimethoprim-Sulfamethoxazole, and Ceftazidime , 2004, Antimicrobial Agents and Chemotherapy.

[34]  Michael T. Wilson,et al.  Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. , 2003, Annual review of microbiology.

[35]  F. Schmitz,et al.  In Vitro Antibacterial Activity and Pharmacodynamics of New Quinolones , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[36]  J. M. Goodson Gingival crevice fluid flow. , 2003, Periodontology 2000.

[37]  M. Timmerman,et al.  A systematic review on the clinical efficacy of subgingival debridement in the treatment of chronic periodontitis. , 2002, Journal of clinical periodontology.

[38]  E. Jumas‐Bilak,et al.  Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. , 2002, International journal of antimicrobial agents.

[39]  S. Socransky,et al.  Antibiotic resistance of subgingival species during and after antibiotic therapy. , 2002, Journal of clinical periodontology.

[40]  G. Blandino,et al.  Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. , 2002, International journal of antimicrobial agents.

[41]  E. Decker The ability of direct fluorescence‐based, two‐colour assays to detect different physiological states of oral streptococci , 2001, Letters in applied microbiology.

[42]  E. Goldstein,et al.  Comparative Activity of Moxifloxacin in Vitro Against Obligately Anaerobic Bacteria , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[43]  L. Mandell,et al.  Comparative In Vitro Activities of Ciprofloxacin, Gemifloxacin, Grepafloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, Trovafloxacin, and Other Antimicrobial Agents against Bloodstream Isolates of Gram-Positive Cocci , 2000, Antimicrobial Agents and Chemotherapy.

[44]  R. Mueller,et al.  Fluoroquinolones in the treatment of Actinobacillus actinomycetemcomitans-associated periodontitis. , 2000, Journal of periodontology.

[45]  Á. Pascual,et al.  Uptake and Intracellular Activity of Moxifloxacin in Human Neutrophils and Tissue-Cultured Epithelial Cells , 1999, Antimicrobial Agents and Chemotherapy.

[46]  S. Trapnell,et al.  The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum. , 1998, Journal of periodontology.

[47]  S. Socransky,et al.  PERIODONTAL DISEASES: PATHOGENESIS AND MICROBIAL FACTORS , 1998 .

[48]  H. Stass,et al.  Pharmacokinetics, Safety, and Tolerability of Ascending Single Doses of Moxifloxacin, a New 8-Methoxy Quinolone, Administered to Healthy Subjects , 1998, Antimicrobial Agents and Chemotherapy.

[49]  J. Hoekstra,et al.  Tissue Concentrations after a Single-Dose, Orally Administered Ofloxacin in Patients with Diabetic Foot Infections , 1998, Foot & ankle international.

[50]  J. Slots,et al.  Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. , 1996, Oral microbiology and immunology.

[51]  M. Seike,et al.  Concentration of ofloxacin in human gingival crevicular fluid after oral administration of Tarivid. , 1989, Journal of periodontal research.

[52]  K. Prior,et al.  Efficacy and safety of adjunctive local moxifloxacin delivery in the treatment of periodontitis. , 2011, Journal of periodontology.

[53]  S. Eick,et al.  Comparison of real-time polymerase chain reaction and DNA-strip technology in microbiological evaluation of periodontitis treatment. , 2011, Diagnostic microbiology and infectious disease.

[54]  J. Gunsolley,et al.  Association of antimicrobial and clinical efficacy: periodontitis therapy with minocycline microspheres. , 2010, Journal of the International Academy of Periodontology.

[55]  D. Kinane,et al.  Nonsurgical mechanical treatment strategies for periodontal disease. , 2010, Dental clinics of North America.

[56]  R. Marcantonio,et al.  Local application of tetracycline solution with a microbrush: an alternative treatment for persistent periodontitis. , 2009, Quintessence international.

[57]  P. Kolenbrander,et al.  Oral microbial communities: biofilms, interactions, and genetic systems. , 2000, Annual review of microbiology.

[58]  Consensus report. Periodontal diseases: pathogenesis and microbial factors. , 1996, Annals of periodontology.

[59]  H. Okada,et al.  Intrapocket chemotherapy in adult periodontitis using a new controlled-release insert containing ofloxacin (PT-01). , 1992, Journal of periodontology.